What is Jin Medical International Ltd. (ZJYL)?

Jin Medical International Ltd. (ZJYL) is a stock in the Healthcare sector, Medical - Instruments & Supplies industry. View full analysis on Stocks360.

What is the current price of ZJYL?

The current price of ZJYL is $2.35. Prices are updated in real time on Stocks360.

What is ZJYL's price-to-earnings (PE) ratio?

ZJYL's trailing twelve-month PE ratio is 16.07, based on current price and earnings per share data available on Stocks360.

What is ZJYL's market capitalization?

ZJYL's market capitalization is $18,394,348.00, placing it in the small-cap tier.

Jin Medical International Ltd. (ZJYL)

Stock analysis · NASDAQ · Healthcare · Medical - Instruments & Supplies

$2.35

Market Cap

$18.39M

PE (TTM)

16.07

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

7.41

Day Range

$1.83 – $2.78

52-wk Range

$1.53 – $8.48

Avg Volume

N/A

Volume

3.64M

Jin Medical International Ltd. (ZJYL) is a publicly traded company in the Healthcare sector. Latest price: $2.35. Market cap $18.39M. Trailing PE 16.07. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-31 · $4.56 2026-10-30 · $2.35 (-48.46%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About Jin Medical International Ltd.

Jin Medical International Ltd. specializes in the conception, production, and worldwide distribution of mobility and daily living aids, including wheelchairs, for individuals with disabilities or restricted movement. Their product range additionally features oxygen concentrators and specialized bathing devices. Established in 2006, the company is headquartered in Changzhou, China, and operates as a subsidiary of Jolly Harmony Enterprises Limited.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	16.07×
P/S (TTM)	0.93×
P/B	0.61×
P/FCF (TTM)	-2.64×
EV / EBITDA	41.69×
EV / Sales	1.52×
Earnings Yield	6.37%
Free Cash Flow Yield	-37.83%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$29.89M
Revenue (TTM)	$19.73M
Net Income (TTM)	$1.17M
Free Cash Flow (TTM)	-$6.96M
Net Debt	$11.50M
Working Capital	$21.63M
Gross Margin	30.62%
Operating Margin	2.12%
Net Margin	5.94%
Return on Equity	3.91%
Return on Invested Capital	0.76%